These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26124159)

  • 1. ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.
    Miley GP; Pou S; Winter R; Nilsen A; Li Y; Kelly JX; Stickles AM; Mather MW; Forquer IP; Pershing AM; White K; Shackleford D; Saunders J; Chen G; Ting LM; Kim K; Zakharov LN; Donini C; Burrows JN; Vaidya AB; Charman SA; Riscoe MK
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5555-60. PubMed ID: 26124159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkoxycarbonate Ester Prodrugs of Preclinical Drug Candidate ELQ-300 for Prophylaxis and Treatment of Malaria.
    Frueh L; Li Y; Mather MW; Li Q; Pou S; Nilsen A; Winter RW; Forquer IP; Pershing AM; Xie LH; Smilkstein MJ; Caridha D; Koop DR; Campbell RF; Sciotti RJ; Kreishman-Deitrick M; Kelly JX; Vesely B; Vaidya AB; Riscoe MK
    ACS Infect Dis; 2017 Oct; 3(10):728-735. PubMed ID: 28927276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Position Biaryl Endochin-like Quinolones with Enhanced Antimalarial Performance.
    Pou S; Winter RW; Dodean RA; Liebman K; Li Y; Mather MW; Nepal B; Nilsen A; Handford MJ; Riscoe TM; Laxson S; Kirtley PJ; Aleshnick M; Zakharov LN; Kelly JX; Smilkstein MJ; Wilder BK; Kortagere S; Vaidya AB; Alday PH; Doggett JS; Riscoe MK
    ACS Infect Dis; 2024 Jul; 10(7):2419-2442. PubMed ID: 38862127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
    Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
    J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELQ-331 as a prototype for extremely durable chemoprotection against malaria.
    Smilkstein MJ; Pou S; Krollenbrock A; Bleyle LA; Dodean RA; Frueh L; Hinrichs DJ; Li Y; Martinson T; Munar MY; Winter RW; Bruzual I; Whiteside S; Nilsen A; Koop DR; Kelly JX; Kappe SHI; Wilder BK; Riscoe MK
    Malar J; 2019 Aug; 18(1):291. PubMed ID: 31455339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
    Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A
    Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
    Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of Deuterated Endochin-Like Quinolones.
    Pou S; Winter RW; Liebman KM; Dodean RA; Nilsen A; DeBarber A; Doggett JS; Riscoe MK
    J Labelled Comp Radiopharm; 2024 May; 67(5):186-196. PubMed ID: 38661253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of endochin-like quinolones for antimalarial activity.
    Winter R; Kelly JX; Smilkstein MJ; Hinrichs D; Koop DR; Riscoe MK
    Exp Parasitol; 2011 Feb; 127(2):545-51. PubMed ID: 21040724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally Bioavailable Endochin-Like Quinolone Carbonate Ester Prodrug Reduces Toxoplasma gondii Brain Cysts.
    Doggett JS; Schultz T; Miller AJ; Bruzual I; Pou S; Winter R; Dodean R; Zakharov LN; Nilsen A; Riscoe MK; Carruthers VB
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32540978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone-3-diarylethers: a new class of antimalarial drug.
    Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
    Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the Optimization of 4(1
    Brockmeyer F; Manetsch R
    Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Two New Endochin-like Quinolones, ELQ-596 and ELQ-650, in Experimental Mouse Models of Human Babesiosis.
    Vydyam P; Chand M; Pou S; Winter RW; Liebman KM; Nilsen A; Doggett JS; Riscoe MK; Ben Mamoun C
    ACS Infect Dis; 2024 Apr; 10(4):1405-1413. PubMed ID: 38563132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bis-alkylamidoxime O-alkylsulfonates as orally available antimalarials.
    Degardin M; Wein S; Gouni S; Tran Van Ba C; Duckert JF; Durand T; Escale R; Vial H; Vo-Hoang Y
    ChemMedChem; 2012 Jun; 7(6):991-1001. PubMed ID: 22544438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diaryl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Reichenberg A; Wiesner J; Weidemeyer C; Dreiseidler E; Sanderbrand S; Altincicek B; Beck E; Schlitzer M; Jomaa H
    Bioorg Med Chem Lett; 2001 Mar; 11(6):833-5. PubMed ID: 11277531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting intramuscular injections of ELQ-331, an antimalarial agent.
    Karunakaran D; Mutyam SK; Fu M; Chen J; Pham KHN; Pou S; Winter RW; Nilsen A; Dodean RA; Smilkstein MJ; Riscoe MK; Shankar G
    Eur J Pharm Sci; 2024 Jul; 198():106795. PubMed ID: 38729224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antimalarial compound ELQ-400 is an unusual inhibitor of the bc
    Song Z; Iorga BI; Mounkoro P; Fisher N; Meunier B
    FEBS Lett; 2018 Apr; 592(8):1346-1356. PubMed ID: 29574797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs of bisthiazolium salts are orally potent antimalarials.
    Vial HJ; Wein S; Farenc C; Kocken C; Nicolas O; Ancelin ML; Bressolle F; Thomas A; Calas M
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15458-63. PubMed ID: 15492221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.